You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨新冠疫苗股高開 德國反對拜登豁免新冠疫苗專利的決定
格隆匯 05-07 09:26
格隆匯5月7日丨新冠疫苗股高開,復星醫藥高開逾5%,康希諾高開逾4%。德國製藥公司BioNTech和總理默克爾先後表示,不認同美國總統拜登5月5日決定在新冠肺炎疫苗上實施專利豁免的決定,但德國外長Maas對美方的疫苗專利豁免持開放態度。BioNTech為美國製藥公司輝瑞的合作伙伴。據證券時報,相關上市公司及投資人士表示,美國放棄對新冠疫苗的知識產權保護還需要一個較長的過程,短期對國內新冠疫苗企業影響不大。實際上,限制疫苗大規模生產的因素還包括設備、原材料、專利之外的knowhow等,並非有了專利就有能力實現生產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account